G1 tetraploidy checkpoint and the suppression of tumorigenesis

Journal of Cellular Biochemistry

Volumn 88, Issue 4, 2003, Pages 673-683

  Margolis, Robert L ^a   Lohez, Olivier D ^a   Andreassen, Paul R ^a,b  

^a INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Aneuploidy; Genomic instability; P53; PRb; Tetraploid checkpoint

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANAPHASE; ANEUPLOIDY; ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CHROMOSOME; GENOME; METAPHASE; MITOSIS; MITOSIS INHIBITION; MITOSIS SPINDLE; PRIORITY JOURNAL; TETRAPLOIDY;

ANEUPLOIDY; ANIMALS; DNA DAMAGE; G1 PHASE; GENES, CDC; HUMANS; METAPHASE; MITOSIS; NEOPLASMS; POLYPLOIDY; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 0037373258     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10411     Document Type: Article

References (77)

1. Abrieu A, Magnaghi-Jaulin L, Kahana JA, Peter M, Castro A, Vigneron S, Lorca T, Cleveland DW, Labbe JC. 2001. Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint. Cell 106:83-93.
2. Adams RR, Carmena M, Earnshaw WC. 2001. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 11:49-54.
3. cdc2 inactivation and mitotic exit in mammalian cells. J Cell Biol 127:789-802.
4. Andreassen PR, Martineau SN, Margolis RL. 1996. Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. Mutat Res 372:181-194.
5. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL. 2001a. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 12:1315-1328.
6. WAF1 induces stable G1 arrest in resulting tetraploid cells. Cancer Res 61:7660-7668.
7. Borel F, Lohez OD, Lacroix FB, Margolis RL. 2002. Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells. Proc Natl Acad Sci USA 99:9819-9824.
8. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501.
9. Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B, Lengauer C. 2002. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 62:1129-1133.
10. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. 1998. Mutations of mitotic checkpoint genes in human cancers. Nature 392:300-303.
11. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. 1999. Genetic instability and Darwinian selection in tumours. Trends Cell Biol 9:M57-M60.
12. Chaudhary N, Courvalin J-C. 1993. Stepwise reassembly of the nuclear envelope at the end of mitosis. J Cell Biol 122:295-306.
13. Cimini D, Howell B, Maddox P, Khodjakov A, Degrassi F, Salmon ED. 2001. Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J Cell Biol 153:517-527.
14. Clarke DJ, Gimenez-Abian JF. 2000. Checkpoints controlling mitosis. Bioessays 22:351-363.
15. Dannenberg JH, van Rossum A, Schuijff L, te Riele H. 2000. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 14:3051-3064.
16. Downes CS, Mullinger AM, Johnson RT. 1991. Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis. Proc Natl Acad Sci USA 88:8895-8899.
17. Drayton S, Peters G. 2002. Immortalisation and transformation revisited. Curr Opin Genet Dev 12:98-104.
18. Fisk HA, Winey M. 2001. The mouse Mps1p-like kinase regulates centrosome duplication. Cell 106:95-104.
19. Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, van Es JH, Breukel C, Wiegant J, Giles RH, Clevers H. 2001. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3: 433-438.
20. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. 1996. Abnormal centrosome amplification in the absence of p53. Science 271:1744-1747.
21. Gorbsky GJ. 2001. The mitotic spindle checkpoint. Curr Biol 11:R1001-R1004.
22. Gorbsky GJ, Chen RH, Murray AW. 1998. Microinjection of antibody to Mad2 protein into mammalian cells in mitosis induces premature anaphase. J Cell Biol 141: 1193-1205.
23. Harbour JF, Dean DC. 2000. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes Dev 14:2393-2409.
24. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
25. Haupt Y, Maya R, Kazaz A, Oren M. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
26. Heselmeyer K, Schrock E, Du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Reid T. 1996. Gain of chromosome 3q defines the transition from cervical dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93:479-484.
27. Hinchcliffe EH, Sluder G. 2002. Two for two: Cdk2 and its role in centrosome doubling. Oncogene 21:6154-6160.
28. Hinchcliffe EH, Miller FJ, Cham M, Khodjakov A, Sluder G. 2001. Requirement of a centrosomal activity for cell cycle progression through G1 into S phase. Science 291: 1547-1550.
29. Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM, Kinzler KW, Vogelstein B, Lengauer C. 2001. Securin is required for chromosomal stability in human cells. Cell 105:445-457.
30. Jin DY, Spencer F, Jeang KT. 1998. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93:81-91.
31. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649-659.
32. Kamijo T, van de Kamp E, Chong MJ, Zindy F, Diehl JA, Sherr CJ, McKinnon PJ. 1999. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. Cancer Res 59:2464-2469.
33. Kaplan KB, Burds AA, Swedlow JR, Bekir SS, Sorger PK, Nathke IS. 2001. A role for the adenomatous polyposis coli protein in chromosome segregation. Nat Cell Biol 3: 429-432.
34. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311.
35. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71:587-597.
36. Khan SH, Moritsugu J, Wahl GM. 2000. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion. Proc Natl Acad Sci USA 97: 3266-3271.
37. Khodjakov A, Rieder CL. 2001. Centrosomes enhance the fidelity of cytokinesis in vertebrates and are required for cell cycle progression. J Cell Biol 153:237-242.
38. Kubbutat MH, Jones SN, Vousden KH. 1997. Regulation of p53 stability by Mdm2. Nature 387:299-303.
39. Lanni JS, Jacks T. 1998. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 18:1055-1064.
40. Lengauer C, Kinzler KW, Vogelstein B. 1997. Genetic instability in colorectal cancers. Nature 386:623-627.
41. Li Y, Benezra R. 1996. Identification of a human mitotic checkpoint gene: hsMAD2. Science 274:246-248.
42. Li R, Sonik A, Stindl R, Rasnick D, Duesberg P. 2000. Aneuploidy vs. gene mutation hypothesis of cancer: Recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci USA 97:3236-3241.
43. Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM. 1996. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 10:934-947.
44. Meraldi P, Honda R, Nigg EA. 2002. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/-cells. EMBO J 21: 483-492.
45. Minn AJ, Boise LH, Thompson CB. 1996. Expression of Bcl-xl and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 10:2621-2631.
46. Nakamura M, Zhou XZ, Lu KP. 2001. Critical role for the EB1 and APC interaction in the regulation of microtubule polymerization. Curr Biol 11:1062-1067.
47. Nicklas RB, Ward SC, Gorbsky GJ. 1995. Kinetochore chemistry is sensitive to tension and may link mitotic forces to a cell cycle checkpoint. J Cell Biol 130:929-939.
48. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
49. Nurse P. 1990. Universal control regulating onset of M-phase. Nature 344:503-508.
50. Ornitz DM, Hammer RE, Messing A, Palmiter RD, Brinster RL. 1987. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science 238:188-193.
51. Prasanth SG, Prasanth KV, Stillman B. 2002. Orc6 involved in DNA replication, chromosome segregation, and cytokinesis. Science 297:1026-1031.
52. Rabinovitch PS, Reid BJ, Haggitt RC, Norwood TH, Rubin CE. 1989. Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest 60:65-71.
53. Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS. 1987. Barrett's esophagus: Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93:1-11.
54. Rieder CL, Schultz A, Cole R, Sluder G. 1994. Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle. J Cell Biol 127:1301-1310.
55. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, Theodorou E, Jacks T. 2000. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 14:3037-3050.
56. Sandberg AA. 1977. Chromosome markers and progression in bladder cancer. Cancer Res 37:2950-2956.
57. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW. 2002. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109:335-346.
58. Schutte B, Reynders MM, Wiggers T, Arends JW, Volovics L, Bosman FT, Blijham GH. 1987. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res 47:5494-5496.
59. Shackney SE, Smith CA, Miller BW, Burholt DR, Murtha K, Giles HR, Ketterer DM, Pollice AA. 1989. Model for the genetic evolution of human solid tumors. Cancer Res 49:3344-3354.
60. Sharp-Baker H, Chen RH. 2001. Spindle checkpoint protein Bub1 is required for kinetochore localization of Mad1, Mad2, Bub3, and CENP-E, independently of its kinase activity. J Cell Biol 153:1239-1250.
61. Sherr CJ. 1996. Cancer cell cycles. Science 274:1672-1677.
62. Skoufias DA, Andreassen PR, Lacroix FB, Wilson L, Margolis RL. 2001. Mammalian Mad2 and Bub1/BubR1 recognize distinct spindle attachment and kinetochore tension checkpoints. Proc Natl Acad Sci USA 98:4492-4497.
63. Stephenson RA, James BC, Gay H, Fair WR, Whitmore WF, Jr., Melamed MR. 1987. Flow cytometry of prostate cancer: Relationship of DNA content to survival. Cancer Res 47:2504-2507.
64. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G. 1998. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17:5001-5014.
65. Stucke VM, Sillje HH, Arnaud L, Nigg EA. 2002. Human Mps1 kinase is required for the spindle assembly checkpoint but not for centrosome duplication. EMBO J 21:1723-1732.
66. Sudakin V, Chan GK, Yen TJ. 2001. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 154:925-936.
67. Tarapore P, Tokuyama Y, Horn HF, Fukasawa K. 2001. Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: Potential role of Ser 315 phosphorylation-dependent centrosome binding of p53. Oncogene 20:6851-6863.
68. Taylor SS, McKeon F. 1997. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89:727-735.
69. Tomkiel J, Cooke CA, Saitoh H, Bernat RL, Earnshaw WC. 1994. CENP-C is required for maintaining proper kinetochore size and for a timely transition to anaphase. J Cell Biol 125:531-545.
70. Torres K, Horwitz SB. 1998. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 58: 3620-3626.
71. Trielli MO, Andreassen PR, Lacroix FB, Margolis RL. 1996. Differential Taxol-dependent arrest of transformed and nontransformed cells in the G1 phase of the cell cycle, and specific-related mortality of transformed cells. J Cell Biol 135:689-700.
72. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. 1996. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 38:713-716.
73. Waters JC, Chen RH, Murray AW, Salmon ED. 1998. Localization of Mad2 to kinetochores depends on microtubule attachment, not tension. J Cell Biol 141:1181-1191.
74. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. 1999. Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1:20-26.
75. Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ, Zambetti GP. 2000. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev 14:2358-2365.
76. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
77. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S. 1998. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy, and transformation. Nat Genet 20:189-193.